J. McGregor

发表

Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

Yichun Hu, D. Bunch, R. Falk, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis

Yichun Hu, D. Bunch, R. Falk, 2015, Annals of the rheumatic diseases.

Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.

Yichun Hu, R. Falk, S. Hogan, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rituximab therapy for membranous nephropathy: a systematic review.

A. Kshirsagar, V. Derebail, A. Bomback, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Reduced CD5+CD24hiCD38hi and interleukin‐10+ regulatory B cells in active anti‐neutrophil cytoplasmic autoantibody‐associated vasculitis permit increased circulating autoantibodies

Y. Hu, D. Bunch, R. Falk, 2015, Clinical and experimental immunology.

Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis.

D. O'Dell, Yichun Hu, D. Bunch, 2012, Journal of the American Society of Nephrology : JASN.

ANCA-associated Vasculitis Patients Have Defective Treg Function Exacerbated by Presence of a Suppression-Resistant Effector Population

D. Bunch, J. Jennette, S. Hogan, 2013 .

Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease.

Yichun Hu, R. Falk, S. Hogan, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

L. Laurin, V. Derebail, R. Falk, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.

Y. Hu, Yichun Hu, R. Falk, 2013, Clinical and experimental rheumatology.

Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

P. Heeringa, S. Holdsworth, Yichun Hu, 2013, The Journal of clinical investigation.

Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

V. Derebail, R. Falk, J. Jennette, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.

Yichun Hu, D. Bunch, R. Falk, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vasculitis: The elusive optimal induction strategy for vasculitis

R. Falk, J. McGregor, 2012, Nature Reviews Nephrology.

What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population

Yichun Hu, R. Falk, S. Hogan, 2014, Journal of autoimmune diseases and rheumatology.